Gentex Analyst Price Targets - Benzinga

Gentex Corp

GNTXNASDAQ

Trade with Public

Trade with Public

$21.08

-0.47-2.18%

마지막 업데이트: Oct 7, 5:04 PM

$21.12

-0.43-2%

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 배당금 비교 옵션 주식 보고서

© 2026 Benzinga | All Rights Reserved

Gentex Analyst Price Targets - Benzinga

Gentex Analyst Price Targets

Wall Street analyst price targets and consensus rating for Gentex (GNTX).

Price Target Range — 12 Quarters

Analyst Consensus — 7 Analysts

2Buy

4Hold

1Sell

Consensus RatingNeutral# Analysts7Avg. Consensus PT$27Upside to Avg. PT+25.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 7, 2026	UBS	Joseph Spak	PT Cut	Neutral	$25→$24
Oct 6, 2026	Goldman Sachs	Mark Delaney	Downgrade	Neutral→Sell	$23→$20
Aug 10, 2026	JP Morgan	Rajat Gupta	PT Cut	Neutral	$28→$27
Jul 9, 2026	UBS	Joseph Spak	PT Cut	Neutral	$26→$25
May 14, 2026	JP Morgan	Rajat Gupta	PT Raise	Neutral	$27→$28
Apr 27, 2026	Baird	David Leiker	PT Raise	Neutral	$25→$26
Apr 27, 2026	B. Riley Securities	Josh Nichols	PT Raise	Buy	$28→$29
Apr 23, 2026	JP Morgan	Ryan Brinkman	PT Cut	Neutral	$28→$27
Apr 14, 2026	UBS	Joseph Spak	PT Cut	Neutral	$25→$24
Feb 2, 2026	B. Riley Securities	Josh Nichols	PT Cut	Buy	$32→$28
Oct 27, 2025	Goldman Sachs	Mark Delaney	PT Cut	Neutral	$30→$27
Oct 20, 2025	JP Morgan	Ryan Brinkman	PT Raise	Neutral	$30→$32
Oct 6, 2025	UBS	Joseph Spak	PT Raise	Neutral	$28→$29
Jul 28, 2025	UBS	Joseph Spak	PT Raise	Neutral	$23→$28
Jul 28, 2025	B. Riley Securities	Josh Nichols	PT Raise	Buy	$28→$32
Jul 28, 2025	Baird	David Leiker	PT Raise	Neutral	$26→$30
Jul 14, 2025	UBS	Joseph Spak	PT Raise	Neutral	$21→$23
Jul 11, 2025	Baird	David Leiker	PT Raise	Neutral	$25→$26
Apr 22, 2025	Guggenheim	Ronald Jewsikow	PT Cut	Buy	$30→$24
Apr 15, 2025	Baird	David Leiker	Downgrade	Outperform→Neutral	$31→$25

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
UBS Maintains Neutral on Gentex, Lowers Price Target to $24

UBS analyst Joseph Spak maintains Gentex (NASDAQ:GNTX) with a Neutral and lowers the price target from $25 to $24.

Benzinga Newsdesk

This Gentex Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday

Analysts downgraded Gentex, Personalis, Goosehead Insurance, cutting ratings and several price targets.

Avi Kapoor

PRO
Goldman Sachs Downgrades Gentex to Sell, Lowers Price Target to $20

Goldman Sachs analyst Mark Delaney downgrades Gentex (NASDAQ:GNTX) from Neutral to Sell and lowers the price target from $23 to $20.

Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Gentex, Lowers Price Target to $27

JP Morgan analyst Rajat Gupta maintains Gentex (NASDAQ:GNTX) with a Neutral and lowers the price target from $28 to $27.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on Gentex, Lowers Price Target to $25

UBS analyst Joseph Spak maintains Gentex (NASDAQ:GNTX) with a Neutral and lowers the price target from $26 to $25.

Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Gentex, Raises Price Target to $28

JP Morgan analyst Rajat Gupta maintains Gentex (NASDAQ:GNTX) with a Neutral and raises the price target from $27 to $28.

Benzinga Newsdesk